• Introduction
  • About Dr. Erin J. Engelson
  • Peer Reviewed Articles
  • Policy, Editorials, and News
  • Astoria STEM Academy High Impact Tutoring
  • Astoria STEM Academy
  • STEM Inspiration
  • SARS Co-V-2
  • Young Scientist Program Events in Astoria, Oregon
  • Astoria STEM Academy Events at a Glance
  • Scholarship Requests
  • Contact Dr. Erin J. Engelson
Menu

Erin J. Engelson, Ph.D.

Street Address
City, State, Zip
Phone Number

Your Custom Text Here

Erin J. Engelson, Ph.D.

  • Introduction
  • About Dr. Erin J. Engelson
  • Peer Reviewed Articles
  • Policy, Editorials, and News
  • Astoria STEM Academy High Impact Tutoring
  • Astoria STEM Academy
  • STEM Inspiration
  • SARS Co-V-2
  • Young Scientist Program Events in Astoria, Oregon
  • Astoria STEM Academy Events at a Glance
  • Scholarship Requests
  • Contact Dr. Erin J. Engelson

Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2

April 24, 2020 Emily Engdahl
Data Lindall et al, 2020.jpeg

Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2

Dr. Johanna Lindahl and I met in 2015 and have shared a lot of wonderful scientific discussions since. I was happy to learn she is currently working in Sweden again after our time together in Kenya.

Dr. Lindahl and her colleagues have described rapid IgG and IgM antibody testing using samples from individuals with previous exposure to SARS-CoV-2.

AUTHORS: Tove Hoffman, Karolina Nissen, Janina Krambrich, Bengt Rönnberg, Dario Akaberi, Mouna Esmaeilzadeh, Erik Salaneck, Johanna Lindahl, & Åke Lundkvist

ABSTRACT: COVID-19 is the most rapidly growing pandemic in modern time, and the need for serological testing is most urgent. Although the diagnostics of acute patients by RT-PCR is both efficient and specific, we are also crucially in need of serological tools for investigating antibody responses and assessing individual and potential herd immunity. We evaluated a commercially available test developed for rapid (within 15 minutes) detection of SARS-CoV-2-specific IgM and IgG by 29 PCR-confirmed COVID-19 cases and 124 negative controls. The results revealed a sensitivity of 69% and 93.1% for IgM and IgG, respectively, based solely on PCR-positivity due to the absence of a serological gold standard. The assay specificities were shown to be 100% for IgM and 99.2% for IgG. This indicates that the test is suitable for assessing previous virus exposure, although negative results may be unreliable during the first weeks after infection. More detailed studies on antibody responses during and post infection are urgently needed.

Infection Ecology & Epidemiology Volume 10, 2020 - Issue 1

← Cryptic transmission of SARS-CoV-2 in Washington StateUW team illustrates the adverse impact of visiting ‘just one friend’ during COVID-19 lockdown →

Site Design By Tine + Bristle